I'm not surprised to see the new contributors to this thread bitch. Those who bought in the neighborhood of 55 and have just recently heard of AGPH must not understand that the deal was in the current price. That's sort of naive, however.
I am surprised, however, to hear some of the old-timers complain. When the stock had taken the steep dive to south of 30, I said that there was only one thing to keep your eye on..... the price that someone would pay to access that sales force. At that time, I said in more than one forum that the price would be in the vicinity of $70/share. I'm not bringing that up to show that I made a decent prediction, but to revisit the responses that I got at that time. Some of those who are bitching now were counting their bucks, and smiling, when people mentioned $70/share (and lower figures).
The deal is already in the price, as the company has been shopped. If you'd like to back out of the WL deal and stay independent, fine, but....... if you could do such....... the market would hand you a $35 stock.
"AGPH online" got launched in misc.invest.stocks in the Spring of '95. Clive Taylor was there. There were the biotech nuts.... John Metcalf, Rudy Saucillo, Jim Silverman, Dr. John Dwyer, Dr. Mike Solomon, Shahram Mori, Dr. John de Castro, Paul Yadlowski, Ron Bartlett, Dr. Purshotam Bhan, Dr. Jerry McLaughlin, Dr. Mark Henderson, Dr. John Loike, John Fitisoff, Dr. Kevin Jones, and many others. I do not believe that any one of them could have anything other than admiration for the job that Peter Johnson and team have done.
I guess you have to come from the frame of "AGPH, and how it was viewed relative to VRTX", circa 1994. So, to all the whiners..... phbbbbbbbbbbbbbbt! The rights to Viracept were obtained from Lilly in January, 1994. *You* try taking a company from that stage to a successful small pharma in five years.
Margie..... I agree with earlier comments. As you know, I took my Johnson-delivered 10 bagger and split, quite some time ago. Since then, I didn't need to do much research to stay on top of where the issues would take the stock. You held steady throughout all of the fear-mongering, bringing the relevant points to the thread and presenting them in a concise fashion. Thanks!
Bottom line with AGPH.... Johnson or Nichols, you got a balanced view of hopes and hurdles. |
